Israeli researchers find way to detect cancer cells before becoming brain tumors

Tel Aviv University research opens the "black box" of malignant melanoma.

By
July 26, 2016 14:19
2 minute read.
Prostate cancer cells

Cancer cells. (photo credit: REUTERS)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

When malignant melanoma – the most dangerous kind of skin cancer – spreads to the brain, it is almost always a death sentence. But now, Tel Aviv University researchers have found a way to detect micrometastases – tiny bunches of spreading cancer cells – months before they reach the brain and develop into fatal tumors.

The mechanisms that govern early metastatic growth and interactions of metastatic cells with the brain micro-environment have long remained shrouded in mystery.

Be the first to know - Join our Facebook page.


According to the research led by Dr. Neta Erez of TAU’s pathology department and just published in Cancer Research, micro-tumor cells hijack astrogliosis, the brain’s natural response to damage or injury, to support metastatic growth.

This breakthrough could lead to the detection of brain cancer in its first stages and permit early intervention.

Erez and her team used mice to study and follow the spontaneous metastasis of melanoma in the brain. They recapitulated all the stages of metastasis – the initial discovery of melanoma in the skin, the removal of the primary tumor, the micrometastatic dissemination of cancer cells across the body, the discovery of a tumor and death.

The detection of metastasis depends on imaging techniques that still can’t detect micrometastases.


Melanoma patients whose initial melanoma was excised believe that everything is fine for months or years following the initial procedure.

But after the primary tumor is removed, micrometastatic cells learn to communicate with cells in their new micro-environment in the brain. These cells are at first hostile to them, but eventually, a tumor appears.

The cells traveled across the body to the brain or other organs but were undetectable at the micro level. When they become detectable, it is already too late for treatment.

Erez dubbed the period of the initial growth of disseminated micrometastatic cells in distant organs the metastasis’s “black box” – the history of melanoma in the brain. “We believe that we have found the tools to characterize this black box,” she said. “And this is key to developing therapeutic approaches that may prevent brain metastatic relapse. Every organ in the body has a defense system that detects intruders,” she explained. “Much of this is regulated by support cells in the brain. When there is tissue damage due to a stroke or viral infection, these cells are activated and induce an inflammatory response.

“At the earliest stages of metastasis, we already see astrogliosis and inflammation. The brain perceives the micrometastatic invasion as tissue damage, activating inflammation – its natural defense mechanism. We found that the inflammation unfortunately gets hijacked by tumor cells that are able to grow faster and penetrate deeper because the blood vessels in the brain are more permeable than in any other part of the body. We found that all of this happens very early on.”

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Weizmann Institute of Science in Rehovot.
December 12, 2018
Weizmann Institute of Science Establishes Institute of Medicinal Chemistry

By YAFIT OVADIA